Rizatriptan Benzoate

CHEMBL1201032 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
391.5 g/mol
LogP
Phase
4

The benzoate salt formulation of rizatriptan available as rapidly dissolving wafers that melt on the tongue without water, ideal for migraine patients who experience nausea. It provides fast-acting relief from migraine headache and associated symptoms like nausea and light sensitivity.

Khối lượng phân tử

391,5000 g/mol

TPSA

87,00 Ų

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1

InChI

InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)

Molecular Formula

C22H25N5O2

HBD / HBA

2 / 5

Liên kết có thể quay

6

Nguyên tử nặng

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

The benzoate salt formulation of rizatriptan available as rapidly dissolving wafers that melt on the tongue without water, ideal for migraine patients who experience nausea. It provides fast-acting relief from migraine headache and associated symptoms like nausea and light sensitivity.

Yes, Rizatriptan Benzoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201032. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 77997. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.